Annotation Detail
Information
- Associated Genes
- CYP2C9
- Associated Variants
-
CYP2C9 MUTATION
CYP2C9 MUTATION - Associated Disease
- Hyperlipidemia
- Source Database
- DisGeNET
- Description
- This study suggests that the CYP2C9 polymorphism may be involved in the lipid-lowering efficacy of rosuvastatin in patients with hyperlipidemia.
- Pubmed
- 26554252
- Section of the abstract supporting the evidence
- CONCLUSIONS
- Number of the section of the abstract supporting the evidence
- 4
- Number of the sentence supporting the evidence
- 15
- Original source reporting the Gene Disease association
- BeFree,GAD
- DisGENET score for the Gene Disease association
- 0.00527694770136467
Drugs